Drawing for ENHANCED HA

USPTO serial 99226554

ENHANCED HA

Reviewed by CopyMark Law Group

Reg. 8396693Status 700Registered
Filing date
Status date
Registration date
Aug 11, 2026
Examiner
PEREIRA FILHO, JOAO BOSCO
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ENHANCED HA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lindsay Heather Kaplan

Lindsay Heather Kaplan TOPSHELF TRADEMARKS LLC8 North Front StreetSuite 2002Kingston, NY 12401

Goods and services

ClassDescriptionStatusFirst use
005Solutions for medical and clinical use in storing and treating cells, blood and blood components; Reagents for blood grouping for medical purposes; Hyaluronic acid for pharmaceutical purposes; Pharmaceutical preparations for wounds; Pharmaceutical preparations for skin care; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for use in regenerative medicine, aesthetic medicine, and dermatology; Pharmaceutical preparations for cellular therapy for the treatment of damaged skin or tissue; Chemical preparations for pharmaceutical or medical purposes, namely, for the preparation of autologous biological products; Biologics in the nature of cells for medical use; Biologics in the nature of pharmaceutical preparations for the treatment of damaged skin or tissue; Biologics in the nature of cells for the treatment of damaged skin or tissue; Biological tissue cultures for medical use; Biological tissue cultures for medical purposes; Reagents for medical use; Biological reagents for medical purposes; Anticoagulants; all of the foregoing containing hyaluronic acid, or used in association with hyaluronic acid, or used before, during or after a hyaluronic acid procedure.ACTIVEAug 19, 2024
010Medical devices, namely, tubing and bag assembly set and other similar or related devices, which process and treat human platelets with clinical medical reagents for the purpose of enabling the refrigerated storage of human platelets for blood groups for use in blood transfusions; Blood drawing apparatus; Blood collection needles; Filters for blood and blood components for medical purposes; Apparatus for taking blood; Blood containers for medical purposes; Blood component separation apparatus for medical purposes; Blood collection bags for veterinary purposes; Blood storage bags for medical purposes; Blood tubing sets for medical purposes; Blood collection bags for medical purposes; Blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical syringes; Hypodermic syringes; all of the foregoing containing hyaluronic acid, or used in association with hyaluronic acid, or used before, during or after a hyaluronic acid procedure.ACTIVEAug 19, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 11, 2026NRCSNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 11, 2026R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Jul 14, 2026CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Jun 22, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 22, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 22, 2026ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 15, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 15, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 15, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 22, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 22, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 22, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 23, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 23, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 23, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 27, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 27, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 27, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 4, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 29, 2025DOCKASSIGNED TO EXAMINER—
Jun 10, 2025TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Jun 10, 2025PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jun 10, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 10, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 10, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance